Compare EOLS & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EOLS | PMM |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.0M | 276.3M |
| IPO Year | 2018 | N/A |
| Metric | EOLS | PMM |
|---|---|---|
| Price | $5.54 | $6.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 98.4K |
| Earning Date | 05-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.68% |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $297,176,000.00 | N/A |
| Revenue This Year | $14.41 | N/A |
| Revenue Next Year | $16.96 | N/A |
| P/E Ratio | ★ N/A | $27.87 |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $4.09 | $5.66 |
| 52 Week High | $13.66 | $6.52 |
| Indicator | EOLS | PMM |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | 56.25 |
| Support Level | $4.74 | $6.06 |
| Resistance Level | $7.29 | N/A |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 62.79 | 47.85 |
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.